Effect of proprotein convertase subtilisin/kexin type 9 inhibitors on lipoprotein(a) still to be unravelled.

Authors :: Sbrana F
Dal Pino B
Bigazzi F
Sampietro T
Source :: European journal of preventive cardiology [Eur J Prev Cardiol] 2019 May; Vol. 26 (7), pp. 782. Date of Electronic Publication: 2019 Jan 28.
Publication Year :: 2019

Subjects :: C-Reactive Protein
Cholesterol, LDL
Humans
Lipoprotein(a)
Proprotein Convertase 9
Subtilisins
Blood Component Removal
Cardiovascular Diseases

Full Text Access

Tools